Pharmaceutical News

RSS

Scientists develop safe, highly efficient method to improve searching of new germicides

Scientists from the Lomonosov Moscow State University in cooperation with colleagues have worked out a safe, not that expensive and highly efficient method, which allows to speed up and improve searching of new germicides.

29 Nov 2016

Preventative strategy in stem cell transplant recipients may help thwart C. diff infections

It may be possible to safely prevent one of the most common - and costly to treat - infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a study from the Abramson Cancer Center at the University of Pennsylvania.

29 Nov 2016

New appointment to accelerate discovery of patient-centred medicines

The new Medicines Discovery Catapult (MDC) is pleased to announce the appointment of Ed Owen to put medical research charities and patient groups at the heart of the development of new therapies in the UK.

29 Nov 2016

New self-regulating smart patch releases blood-thinning drugs when necessary

An interdisciplinary team of researchers has developed a smart patch designed to monitor a patient's blood and release blood-thinning drugs as needed to prevent the occurrence of dangerous blood clots - a condition known as thrombosis.

29 Nov 2016

UT Austin researchers develop new oral capsule for treating hemophilia patients

In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.

29 Nov 2016

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.

28 Nov 2016

Study finds abnormally low blood flow in the brain of marijuana users

As the U.S. races to legalize marijuana for medicinal and recreational use, a new, large scale brain imaging study gives reason for caution.

28 Nov 2016

Private practitioners urge patients to choose physical therapy over opioids to manage pain

Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.

26 Nov 2016

New anti-inflammatory drug reduces death of existing brain cells then repairs damage after stroke

Researchers at The University of Manchester have discovered that a potential new drug reduces the number of brain cells destroyed by stroke and then helps to repair the damage.

25 Nov 2016

Organic chemists develop method for rapid formation of optically active α-aminocarbonyl therapeutics

A team of organic chemists at ITbM, Nagoya University, has developed a new reaction to directly install amines into carbonyl compounds using their unique phase-transfer catalyst.

24 Nov 2016

Magnesium deficiency can cause sleep deprivation, say health experts

Magnesium deficiency could be part of the reason you toss and turn at night, say health pioneers BetterYou following ITV’s 'Tonight – Why can’t Britain sleep?' programme which aired yesterday (17 November).

From BetterYou Ltd 24 Nov 2016

UAB physician calls for better education, legislation to help patients with opioid abuse

The U.S. opioid epidemic has evolved so much in the last four years that current federal policy responses risk diminishing returns in saving human lives, according to a new peer-reviewed perspective by University of Alabama at Birmingham Associate Professor of Preventive medicine Stefan Kertesz, M.D. His perspective was published online in the addiction journal Substance Abuse.

24 Nov 2016

Cancer gene mutations can predict response to less intensive treatment in AML patients

Patients with the most lethal form of acute myeloid leukemia (AML) - based on genetic profiles of their cancers - typically survive for only four to six months after diagnosis, even with aggressive chemotherapy.

23 Nov 2016

New vaccine shows potential to decrease risk of fatal opioid overdose

Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone and hydrocodone in animal models.

23 Nov 2016

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.

23 Nov 2016

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

It is not only overseas holidays that can be ruined by the dreaded Traveller's Diarrhoea.

23 Nov 2016

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.

23 Nov 2016

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Enabling the arrival of advanced therapies from pre-clinical stages to industrial production and clinical application: this is the objective of ADVANCECAT project, led by the University of Barcelona and Ferrer, and build up by eighteen entities of the health field in which there are two universities, twelve biomedical research institutes or private foundations, and four companies.

23 Nov 2016

Study reveals new insights into drug-caused deaths among health care professionals

An Australian-first study conducted by Monash University has found that from 2003-2013 nearly five deaths per 1000 employed Australian health care professionals were caused by drugs, with a significant association between specific professions and drug type.

23 Nov 2016

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

The University of Utah College of Pharmacy's Anticonvulsant Drug Development Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health to test drugs to treat epilepsy, and the major focus of the project is to address needs that affect millions of people worldwide -identify novel investigational compounds to prevent the development of epilepsy or to treat refractory, or drug-resistant, epilepsy.

23 Nov 2016

Pharmaceutical News

Scientists develop safe, highly efficient method to improve searching of new germicides

Preventative strategy in stem cell transplant recipients may help thwart C. diff infections

New appointment to accelerate discovery of patient-centred medicines

New self-regulating smart patch releases blood-thinning drugs when necessary

UT Austin researchers develop new oral capsule for treating hemophilia patients

NIH-supported first HIV vaccine efficacy study begins in South Africa

Study finds abnormally low blood flow in the brain of marijuana users

Private practitioners urge patients to choose physical therapy over opioids to manage pain

New anti-inflammatory drug reduces death of existing brain cells then repairs damage after stroke

Organic chemists develop method for rapid formation of optically active α-aminocarbonyl therapeutics

Magnesium deficiency can cause sleep deprivation, say health experts

UAB physician calls for better education, legislation to help patients with opioid abuse

Cancer gene mutations can predict response to less intensive treatment in AML patients

New vaccine shows potential to decrease risk of fatal opioid overdose

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Study reveals new insights into drug-caused deaths among health care professionals

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News